Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol versus oral iron in pediatric iron deficiency anemia with nondialysis-dependent chronic kidney disease
2010-019388-12Phase 3Completed
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- Aug 2010
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of ferumoxytol in iron deficiency anemia (IDA), sponsored by AMAG Pharmaceuticals, Inc.. Started Aug 2010; status: completed.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2010-019388-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019388-12.